Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 280

    1.

    Biomarkers to discern transplantation tolerance after allogeneic hematopoietic cell transplantation.

    Pidala J, Bloom GC, Enkemann S, Eschrich S, Lancaster J, Anasetti C.

    Biol Blood Marrow Transplant. 2009 Nov 13. [Epub ahead of print]PMID: 19922809 [PubMed - as supplied by publisher]Related articles

    2.

    Bortezomib restores stroma-mediated APO2L/TRAIL apoptosis resistance in multiple myeloma.

    Perez LE, Parquet N, Mead M, Anasetti C, Dalton W.

    Eur J Haematol. 2009 Nov 17. [Epub ahead of print]PMID: 19922463 [PubMed - as supplied by publisher]Related articles

    3.

    Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention.

    Pidala J, Anasetti C, Jim H.

    Br J Haematol. 2009 Nov 16. [Epub ahead of print]PMID: 19919651 [PubMed - as supplied by publisher]Related articles

    4.

    Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation.

    Pidala J, Anasetti C, Kharfan-Dabaja MA, Cutler C, Sheldon A, Djulbegovic B.

    Biol Blood Marrow Transplant. 2009 Nov;15(11):1415-21. Epub 2009 Sep 1.PMID: 19822301 [PubMed - in process]Related articles

    5.

    Th17 cells are sufficient but not necessary to induce acute graft-versus-host disease.

    Iclozan C, Yu Y, Liu C, Liang Y, Yi T, Anasetti C, Yu XZ.

    Biol Blood Marrow Transplant. 2009 Oct 2. [Epub ahead of print]PMID: 19804837 [PubMed - as supplied by publisher]Related articles

    6.

    Impending challenges in the hematopoietic stem cell transplantation physician workforce.

    Gajewski JL, LeMaistre CF, Silver SM, Lill MC, Selby GB, Horowitz MM, Rizzo JD, Heslop HE, Anasetti C, Maziarz RT.

    Biol Blood Marrow Transplant. 2009 Dec;15(12):1493-501. Epub 2009 Sep 23.PMID: 19781658 [PubMed - in process]Related articles

    7.

    Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease.

    Pidala J, Kim J, Perkins J, Field T, Fernandez H, Perez L, Ayala E, Kharfan-Dabaja M, Anasetti C.

    Bone Marrow Transplant. 2009 Sep 21. [Epub ahead of print]PMID: 19767783 [PubMed - as supplied by publisher]Related articles

    8.

    Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.

    Gergis U, Markey K, Greene J, Kharfan-Dabaja M, Field T, Wetzstein G, Schell MJ, Huang Y, Anasetti C, Perkins J.

    Bone Marrow Transplant. 2009 Aug 17. [Epub ahead of print]PMID: 19684623 [PubMed - as supplied by publisher]Related articles

    9.

    A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.

    Salinger DH, Blough DK, Vicini P, Anasetti C, O'Donnell PV, Sandmaier BM, McCune JS.

    Clin Cancer Res. 2009 Aug 15;15(16):5280-7. Epub 2009 Aug 11.PMID: 19671874 [PubMed - in process]Related articles

    10.

    Infliximab for managing steroid-refractory acute graft-versus-host disease.

    Pidala J, Kim J, Field T, McBride A, Kharfan-Dabaja M, Perkins J, Fernandez H, Perez L, Ayala E, Anasetti C.

    Biol Blood Marrow Transplant. 2009 Sep;15(9):1116-21.PMID: 19660725 [PubMed - indexed for MEDLINE]Related articles

    11.

    5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation.

    Field T, Perkins J, Huang Y, Kharfan-Dabaja MA, Alsina M, Ayala E, Fernandez HF, Janssen W, Lancet J, Perez L, Sullivan D, List A, Anasetti C.

    Bone Marrow Transplant. 2009 Jun 22. [Epub ahead of print]PMID: 19543327 [PubMed - as supplied by publisher]Related articles

    12.

    Sirolimus as primary treatment of acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.

    Pidala J, Kim J, Anasetti C.

    Biol Blood Marrow Transplant. 2009 Jul;15(7):881-5.PMID: 19539221 [PubMed - indexed for MEDLINE]Related articles

    13.

    Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.

    Carnevale-Schianca F, Leisenring W, Martin PJ, Furlong T, Schoch G, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Kiem HP, Storb R, McDonald GB, Nash RA.

    Biol Blood Marrow Transplant. 2009 Jun;15(6):749-56.PMID: 19450760 [PubMed - indexed for MEDLINE]Related articles

    14.

    Abundant c-Fas-associated death domain-like interleukin-1-converting enzyme inhibitory protein expression determines resistance of T helper 17 cells to activation-induced cell death.

    Yu Y, Iclozan C, Yamazaki T, Yang X, Anasetti C, Dong C, Yu XZ.

    Blood. 2009 Jul 30;114(5):1026-8. Epub 2009 May 8.PMID: 19429865 [PubMed - indexed for MEDLINE]Related articles

    15.

    Quality of life after allogeneic hematopoietic cell transplantation.

    Pidala J, Anasetti C, Jim H.

    Blood. 2009 Jul 2;114(1):7-19. Epub 2009 Mar 31. Review.PMID: 19336756 [PubMed - indexed for MEDLINE]Related articles

    16.

    Selecting donor recipients.

    Anasetti C.

    Biol Blood Marrow Transplant. 2009 Mar;15(3):393-4. No abstract available. PMID: 19203734 [PubMed - indexed for MEDLINE]Related articles

    17.

    Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants.

    Davies SM, Wang D, Wang T, Arora M, Ringden O, Anasetti C, Pavletic S, Casper J, Macmillan ML, Sanders J, Wall D, Kernan NA.

    Biol Blood Marrow Transplant. 2009 Mar;15(3):360-6.PMID: 19203727 [PubMed - indexed for MEDLINE]Related articles

    18.

    The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

    Ringdén O, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Gupta V, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, Marks DI, McCarthy PL, Cowan MJ, Petersdorf EW, Russell JA, Schiller GJ, Schouten H, Spellman S, Verdonck LF, Wingard JR, Horowitz MM, Arora M.

    Blood. 2009 Mar 26;113(13):3110-8. Epub 2008 Dec 4.PMID: 19059878 [PubMed - indexed for MEDLINE]Related articles

    19.

    What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation?

    Anasetti C.

    Best Pract Res Clin Haematol. 2008 Dec;21(4):691-7. Review.PMID: 19041609 [PubMed - indexed for MEDLINE]Related articles

    20.

    Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

    Hahn T, McCarthy PL Jr, Zhang MJ, Wang D, Arora M, Frangoul H, Gale RP, Hale GA, Horan J, Isola L, Maziarz RT, van Rood JJ, Gupta V, Halter J, Reddy V, Tiberghien P, Litzow M, Anasetti C, Pavletic S, Ringdén O.

    J Clin Oncol. 2008 Dec 10;26(35):5728-34. Epub 2008 Nov 3.PMID: 18981462 [PubMed - indexed for MEDLINE]Related articles

    21.

    CD28 controls differentiation of regulatory T cells from naive CD4 T cells.

    Guo F, Iclozan C, Suh WK, Anasetti C, Yu XZ.

    J Immunol. 2008 Aug 15;181(4):2285-91.PMID: 18684917 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Chemotherapy or allografting for young adults with high-risk ALL?

    Anasetti C.

    Blood. 2008 Jun 15;111(12):5755; author reply 5755. No abstract available. PMID: 18544698 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival.

    Weisdorf D, Spellman S, Haagenson M, Horowitz M, Lee S, Anasetti C, Setterholm M, Drexler R, Maiers M, King R, Confer D, Klein J.

    Biol Blood Marrow Transplant. 2008 Jul;14(7):748-58.PMID: 18541193 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Bone marrow stroma confers resistance to Apo2 ligand/TRAIL in multiple myeloma in part by regulating c-FLIP.

    Perez LE, Parquet N, Shain K, Nimmanapalli R, Alsina M, Anasetti C, Dalton W.

    J Immunol. 2008 Feb 1;180(3):1545-55.PMID: 18209050 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants.

    Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL; National Marrow Donor Program.

    Biol Blood Marrow Transplant. 2008 Jan;14(1):1-6. Review. No abstract available. PMID: 18158954 [PubMed - indexed for MEDLINE]Related articles

    26.

    Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival.

    Eapen M, Logan BR, Confer DL, Haagenson M, Wagner JE, Weisdorf DJ, Wingard JR, Rowley SD, Stroncek D, Gee AP, Horowitz MM, Anasetti C.

    Biol Blood Marrow Transplant. 2007 Dec;13(12):1461-8. Epub 2007 Oct 10.PMID: 18022576 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.

    Ferrara JL, Anasetti C, Stadtmauer E, Antin J, Wingard J, Lee S, Levine J, Schultz K, Appelbaum F, Negrin R, Giralt S, Bredeson C, Heslop H, Horowitz M.

    Biol Blood Marrow Transplant. 2007 Nov;13(11):1268-85.PMID: 17950914 [PubMed - indexed for MEDLINE]Related articles

    28.

    Beta2 integrins separate graft-versus-host disease and graft-versus-leukemia effects.

    Liang Y, Liu C, Djeu JY, Zhong B, Peters T, Scharffetter-Kochanek K, Anasetti C, Yu XZ.

    Blood. 2008 Jan 15;111(2):954-62. Epub 2007 Oct 10.PMID: 17928532 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

    Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, Fernandez-Vina M, Flomenberg N, Horowitz M, Hurley CK, Noreen H, Oudshoorn M, Petersdorf E, Setterholm M, Spellman S, Weisdorf D, Williams TM, Anasetti C.

    Blood. 2007 Dec 15;110(13):4576-83. Epub 2007 Sep 4.PMID: 17785583 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Hematopoietic cell transplantation for chronic lymphocytic leukemia: an evolving concept.

    Kharfan-Dabaja MA, Anasetti C, Santos ES.

    Biol Blood Marrow Transplant. 2007 Apr;13(4):373-85. Review.PMID: 17382245 [PubMed - indexed for MEDLINE]Related articles

    31.

    Sympathectomy protects denervated skin from graft-versus-host disease.

    Kharfan-Dabaja MA, Anasetti C, Ferrara JL.

    Biol Blood Marrow Transplant. 2007 Mar;13(3):369-70. No abstract available. PMID: 17317591 [PubMed - indexed for MEDLINE]Related articles

    32.

    To ablate or not to ablate? HSCs in the T cell driver's seat.

    Anasetti C, Mulé JJ.

    J Clin Invest. 2007 Feb;117(2):306-10.PMID: 17273553 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients.

    Jacobs SR, Jacobsen PB, Booth-Jones M, Wagner LI, Anasetti C.

    J Pain Symptom Manage. 2007 Jan;33(1):13-23.PMID: 17196903 [PubMed - indexed for MEDLINE]Related articles

    34.

    Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature.

    Kharfan-Dabaja MA, Ayala E, Greene J, Rojiani A, Murtagh FR, Anasetti C.

    Bone Marrow Transplant. 2007 Jan;39(2):101-7. Epub 2006 Dec 4. Review. Erratum in: Bone Marrow Transplant. 2007 Feb;39(4):253-4. PMID: 17143300 [PubMed - indexed for MEDLINE]Related articles

    35.

    Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans.

    Green MR, Anasetti C, Sandin RL, Rolfe NE, Greene JN.

    J Oncol Pharm Pract. 2006 Sep;12(3):179-81.PMID: 17022872 [PubMed - indexed for MEDLINE]Related articles

    36.

    The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.

    Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, Anasetti C, Kamani N, Miller JS, Weisdorf D, Davies SM; KIR Study Group, Center for International Blood and Marrow Transplantation Research.

    Biol Blood Marrow Transplant. 2006 Aug;12(8):876-84.PMID: 16864058 [PubMed - indexed for MEDLINE]Related articles

    37.

    Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells.

    Yu XZ, Liang Y, Nurieva RI, Guo F, Anasetti C, Dong C.

    J Immunol. 2006 Jun 15;176(12):7394-401.PMID: 16751384 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    ASBMT committee report: white paper on measurement of quality outcomes.

    Jones RB, Anasetti C, Appel P, DiPersio J, Heslop H, Lemaistre F, Silver S, Sirilla J, Stiff P; Committee on Hematopoietic Cell Therapy Quality Outcomes.

    Biol Blood Marrow Transplant. 2006 May;12(5):594-7. No abstract available. PMID: 16635795 [PubMed - indexed for MEDLINE]Related articles

    39.

    Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

    Deeg HJ, Storer BE, Boeckh M, Martin PJ, McCune JS, Myerson D, Heimfeld S, Flowers ME, Anasetti C, Doney KC, Hansen JA, Kiem HP, Nash RA, O'Donnell PV, Radich JP, Sandmaier BM, Scott BL, Sorror ML, Warren EH, Witherspoon RP, Woolfrey A, Appelbaum FR, Storb R.

    Biol Blood Marrow Transplant. 2006 May;12(5):573-84.PMID: 16635793 [PubMed - indexed for MEDLINE]Related articles

    40.

    T regulatory cells as an immunotherapy for transplantation.

    Albert MH, Anasetti C, Yu XZ.

    Expert Opin Biol Ther. 2006 Apr;6(4):315-24. Review.PMID: 16548760 [PubMed - indexed for MEDLINE]Related articles

    41.

    Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.

    Yu XZ, Albert MH, Anasetti C.

    J Immunol. 2006 Mar 15;176(6):3383-90.PMID: 16517706 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Are matched unrelated donor transplants justified for AML in CR1?

    Anasetti C, Perkins J, Nieder ML, Field T.

    Best Pract Res Clin Haematol. 2006;19(2):321-8. Review.PMID: 16516129 [PubMed - indexed for MEDLINE]Related articles

    43.

    The 2006 BBMT Education Supplement.

    Anasetti C.

    Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):1. No abstract available. PMID: 16399576 [PubMed - indexed for MEDLINE]Related articles

    44.

    Memory stem cells sustain disease.

    Yu XZ, Anasetti C.

    Nat Med. 2005 Dec;11(12):1282-3. No abstract available. PMID: 16333266 [PubMed - indexed for MEDLINE]Related articles

    45.

    Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.

    Albert MH, Liu Y, Anasetti C, Yu XZ.

    Eur J Immunol. 2005 Sep;35(9):2598-607.PMID: 16078276 [PubMed - indexed for MEDLINE]Related articles

    46.

    Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.

    Pavletic SZ, Khouri IF, Haagenson M, King RJ, Bierman PJ, Bishop MR, Carston M, Giralt S, Molina A, Copelan EA, Ringdén O, Roy V, Ballen K, Adkins DR, McCarthy P, Weisdorf D, Montserrat E, Anasetti C.

    J Clin Oncol. 2005 Aug 20;23(24):5788-94. Epub 2005 Jul 25.PMID: 16043827 [PubMed - indexed for MEDLINE]Related articles

    47.

    Selection of unrelated donors for hematopoietic cell transplantation.

    Field T, Anasetti C.

    Curr Hematol Rep. 2005 Jul;4(4):270-5.PMID: 16009041 [PubMed - indexed for MEDLINE]Related articles

    48.

    A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.

    Nash RA, Johnston L, Parker P, McCune JS, Storer B, Slattery JT, Furlong T, Anasetti C, Appelbaum FR, Lloid ME, Deeg HJ, Kiem HP, Martin PJ, Schubert MM, Witherspoon RP, Forman SJ, Blume KG, Storb R.

    Biol Blood Marrow Transplant. 2005 Jul;11(7):495-505.PMID: 15983549 [PubMed - indexed for MEDLINE]Related articles

    49.

    A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.

    Carpenter PA, Lowder J, Johnston L, Frangoul H, Khoury H, Parker P, Jerome KR, McCune JS, Storer B, Martin P, Appelbaum F, Abonour R, Westervelt P, Anasetti C.

    Biol Blood Marrow Transplant. 2005 Jun;11(6):465-71.PMID: 15931635 [PubMed - indexed for MEDLINE]Related articles

    50.

    Prevention of lethal acute GVHD with an agonistic CD28 antibody and rapamycin.

    Albert MH, Yu XZ, Martin PJ, Anasetti C.

    Blood. 2005 Feb 1;105(3):1355-61. Epub 2004 Sep 30.PMID: 15459004 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...